55 YoungA
From the very beginning, she has been incredibly knowledgeable, caring, attentive, and supportive throughout my entire hormone journey
Studies have indicated that Semaglutide can reduce the risk of major cardiovascular events, such as heart attacks and strokes, in people with type 2 diabetes
namely, dihydroxyphenylalanine, dityrosine and a cross-linked residue consistent with a hydroxylated dityrosine residue 26
If additional weight reduction is needed in patients with type 2 diabetes mellitus treated with WEGOVY 25 mg tablets, consider switching to WEGOVY 1.7 mg injection and follow the recommended dosage escalation for WEGOVY injection [see Dosage and Administration (2.2), Use in Specific Populations (8.6), Clinical Pharmacology (12.3)]
The semaglutide component drives the primary weight loss effect